The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term overall survival after isolated liver perfusion with melphalan in patients with isolated liver metastases of uveal melanoma (SCANDIUM trial).
 
Axel Nelson
No Relationships to Disclose
 
Amir Shafazand
Employment - Icom plc
 
Charlotta All-Eriksson
No Relationships to Disclose
 
Christian Cahlin
Stock and Other Ownership Interests - Hansa Biopharma; Hansa Biopharma (I)
 
Nils Elander
No Relationships to Disclose
 
Hildur Helgadottir
Honoraria - Bristol-Myers Squibb; MSD; Pierre Fabre
Consulting or Advisory Role - MSD; Novartis
 
Jens Folke Kiilgaard
No Relationships to Disclose
 
Sara Kinhult
No Relationships to Disclose
 
Ingrid Ljuslinder
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
 
Jan Erik Mattsson
No Relationships to Disclose
 
Magnus Rizell
No Relationships to Disclose
 
Malin Sternby Eilard
No Relationships to Disclose
 
Gustav J. Ullenhag
Stock and Other Ownership Interests - Essity; Oncopeptides
Honoraria - Bristol-Myers Squibb; MSD; Novartis; Pierre Fabre
Consulting or Advisory Role - Alligator Bioscience; Bristol-Myers Squibb; Incyte; Lidds; MSD; Novartis; SeqCure Immunology
 
Jonas A Nilsson
Stock and Other Ownership Interests - SATMED Ventures AB
 
Lars Ny
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Pierre Fabre; Sanofi; Zealth
Speakers' Bureau - Bristol-Myers Squibb/Celgene; GlaxoSmithKline; LEO Pharma; Miltenyi Biotec; MSD; Novartis; Pfizer
Research Funding - MSD (Inst); Syndax (Inst)
 
Per Lindner
Consulting or Advisory Role - Pierre Fabre
 
Roger Olofsson Bagge
Stock and Other Ownership Interests - SATMEG Ventures
Consulting or Advisory Role - BD Bard; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pierre Fabre; Roche; Sanofi
Speakers' Bureau - Roche
Research Funding - BMS (Inst); Endomagnetics (Inst); NeraCare GmbH (Inst); Skyline Diagnostics (Inst)